{"id":372312,"title":"Draft Guidance Document for Industry and Practitioners on the Special Access Program (SAP) for Drugs - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-04-11","captureTimestamp":"2026-04-11T16:36:24.722000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/draft-guidance-industry-practitioners-special-access-program/document.html","snippet":"Draft Guidance Document for Industry and Practitioners on the Special Access Program (SAP) for Drugs Download the alternative format (PDF format, 332.03 KB, 29 pages) Organization: Health Canada Published: 2019/05/10 This guidance document is being distributed for comment…","rawSnapshotUrl":"/api/snapshots/raw/372312","browseUrl":"https://replay.healtharchive.ca/job-6/20260411163624/https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/draft-guidance-industry-practitioners-special-access-program/document.html#ha_snapshot=372312","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}